drugset / Trial / NCT01461824
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
The investigators are doing this study to look at how different doses of the Depot medroxyprogesterone acetate (DMPA) shot effect weight gain and bone mineral density in teens. The investigators hope that what the investigators learn from this study will be used to develop ways to keep girls from gaining weight or losing bone density when receiving DMPA.
Timeline
- Start
- 2011-09
- Primary completion
- 2015-04
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | medroxyprogesterone acetate | Other / unclassified | 75 mg | Intramuscular |
| Subject | medroxyprogesterone acetate | Other / unclassified | 104 mg | Intramuscular |
| Subject | medroxyprogesterone acetate | Other / unclassified | 150 mg | Intramuscular |